Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (6) | Back to Search
Target-mediated drug metabolic characteristics of TCP-1,a novel peptide to diagnose early colorectal cancer
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-019-Tuesday
- By: FENG, Ru (Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China)
- Co-author(s): Bao-Ying Wen: Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Ru Feng: Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Min Huang: Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Yan Wang: Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China - Abstract:
Backgrounds
A nine cyclic peptide (TCP-1) showed an excellent specificity to colorectal cancer with diameter as small as 2 mm in our previous work.Aims
To study the target-mediated metabolic characteristics and the specificity to colorectal cancer (CRC) of the new peptide TCP-1.Methods
Pharmacokinetics of TCP-1 in both mice and tumor-bearing mice.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023